跳至主要内容
临床试验/JPRN-UMIN000030674
JPRN-UMIN000030674已完成未知

Examining the role of serum periostin as a prognostic marker of asthma - test for serum periostin as a prognostic marker of asthma

Kyoto University0 个研究点目标入组 78 人开始时间: 2018年1月11日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
78

研究概览

简要总结

High serum periostin levels at baseline may predict future requirement for highly intensive asthma treatment for type-2 inflammation, i.e., the need for increasing high dose ICS, SCS use or omalizumab. In "Assessment of serum periostin level as a predictor of requirement forintensive treatment for type-2 inflammation in asthmatics in future: A follow-up study of the KiHAC cohort".

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who expressed a denial of secondary use to other research.

研究者

相似试验